Session Datesort descending
A New Chapter for Oral Precision Therapies in Thyroid Cancer: RET Inhibitors 01/28/2022 - 8:00am to 9:00am EST
FLT3 Mutation in Acute Myeloid Leukemia 02/04/2022 - 8:00am to 9:00am EST
Multidisciplinary Perspectives in Advanced HCC: A Focus on Immune Checkpoint Inhibitors 02/11/2022 - 8:00am to 9:00am EST
Relapsed/Refractory Diffuse Large B-Cell Lymphoma 02/18/2022 - 8:00am to 9:00am EST
Evolution of Therapeutics in Aggressive B-Cell Lymphomas 02/25/2022 - 8:00am to 9:00am EST
Extranodal Nasal Type NK/T-cell Lymphoma 03/04/2022 - 8:00am to 9:00am EST
A Team-Based Approach to Multi-modality Treatment for Early Non-Small Cell Lung Cancer (eNSCLC) in the Era of Immunotherapies 03/11/2022 - 8:00am to 9:00am EST
Metastatic Colon Cancer 03/18/2022 - 8:00am to 9:00am EDT
Myeloproliferative Neoplasms Update 2022 03/25/2022 - 8:00am to 9:00am EDT
A case of IDH-mutant 1p/19q-codeleted oligodendroglioma 04/01/2022 - 8:00am to 9:00am EDT

Pages